Combined colonic cancer treatment with vitamin D analogs and irinotecan or oxaliplatin.

Abstract

The obtained results suggest that vitamin D analogs could be used in combined colonic cancer treatment with irinotecan or oxaliplatin. However, the regulation of ERK1/2 expression by both analogs and oxaliplatin may explain the observed antagonistic interactions.